靶点针对疾病信息17(本栏目收费,不能显示细节,电话13136136841)
靶点针对疾病信息
TARGNAME
Opioid receptor kappa (OPRK1)
INDICATI
Approved Non-specific cutaneous vascular sympton [ICD-11: ME64]
INDICATI
Approved Pain [ICD-11: MG30-MG3Z]
INDICATI
Approved Prurigo [ICD-11: EC91]
INDICATI
Approved Pruritus [ICD-11: EC90]
INDICATI
Phase 3 Irritable bowel syndrome [ICD-11: DD91]
INDICATI
Phase 2/3 Chronic pain [ICD-11: MG30]
INDICATI
Phase 2 Depression [ICD-11: 6A70-6A7Z]
INDICATI
Phase 2 Substance abuse [ICD-11: 6C40]
INDICATI
Phase 1 Bipolar disorder [ICD-11: 6A60]
INDICATI
Phase 1 Coronary vasospastic disease [ICD-11: BA85]
INDICATI
Phase 1 Opioid use disorder [ICD-11: 6C43]
INDICATI
Discontinued in Phase 1 Unspecific substance use disorder [ICD-11: 6C4Z]
INDICATI
Preclinical Obesity [ICD-11: 5B80-5B81]
INDICATI
Terminated Neurodegenerative disorder [ICD-11: 8A20-8A23]